Core Scientific Inc. (CORZ) 12-Month Stock Forecast & Price Target Cone

$13.25 -8.18% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $13.03

Core Scientific Inc. (CORZ) carries a Roarable Rating of E (Strong Sell) with 26/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $4.64B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on CORZ Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is CORZ stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-02, Core Scientific Inc. (NASDAQ: CORZ) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 26/100 at a spot price of $13.25 (-8.18% 1D, market cap $4.64B). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 3/20, and SEC Balance-Sheet Forensics 5/20. Across 1096 tracked Financials issuers, CORZ ranks #1055 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does CORZ compare to BLSH and SEZL in the Financials sector?
▼

Within the Financials sector (Finance: Consumer Services), CORZ carries a Roarable E (26/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, BLSH (Bullish) holds a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $4.54B) and SEZL (Sezzle Inc.) posts a B+ grade (80/100 RQD, P/E N/A, ROIC 38.6%, cap $4.52B). Among the 5-stock peer group, NNI leads on earnings multiple (10.3x) while SEZL leads on capital efficiency (38.6% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for CORZ?
▼

Per CORZ's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001839341), Core Scientific Inc. generated $319.0M in revenue (-37.5% YoY), -$288.6M in net income, and -$450.8M in free cash flow against $2.35B in total assets and $1.06B in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $13.03 (-1.66%)🧬 Dilution Drag (+1.92% YoY Shares)⚙️ Cash Engine: 4/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (26/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-10.5% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERRED ALERT • E
025507510026
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk E
Cash (4)Whales (6)SEC (8)Macro (3)CEO (5)
Each axis scored 0–20
12M PRICE TARGET CONE-14.4% Base Target
$32 Bull$11 Base$9 Bear
📬 FREE CORZ RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CORZ)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (26/100 Composite)
🔍 WHY CORZ SCORES 26/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (31% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 5/9

▲ #2 Bullish Driver: Whale & Options Positioning+6/20 pts (23% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▼ #1 Drag / Risk Factor: Macro Regime Fit4/20 pts (-16 pt drag)

Macro rate sensitivity & RSI-14 (46.9) create a -16 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
34
Grade E$15.43-10.6% Next Q
Q2 (-2Q)
31
Grade E$13.79+3.5% Next Q
Q3 (-1Q)
29
Grade E$14.27-7.1% Next Q
Current
26
Grade E$13.25-10.5% Hist 90D α
Trajectory: E (34) → E (26)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a CORZ Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While CORZ currently carries a cautious 26/100 (E) rating due to Macro Regime Fit (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Financials with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($16.07) and Max Pain ($13.91) forces dealer call-delta covering toward $31.98.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.92% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $CORZ• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “CORZ Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your CORZ Position Size: $10,000

Shares at $13.25: 754.7 sh
$1,000$10,000$25,000$50,000$100,000
12M Bear Case FloorTarget $8.85
$6,679
$-3,321 (-33.2%)
12M Consensus BaseTarget $11.34
$8,558
$-1,442 (-14.4%)
12M Bull Case BreakoutTarget $31.98
$24,136
+$14,136 (+141.4%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (35 Desks)

Street Historical Accuracy: 64/100
● Strong Buy / Buy: 17● Hold: 9● Sell: 9
Wall Street FirmStance12M Target1Y AccuracyTrack Grade
Morgan StanleyInstitutional Equity DeskHOLD$1274%A
Goldman SachsSector Coverage LeadUNDERPERFORM$3069%B
JP MorganUS Large-Cap ResearchSELL$1058%C
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring CORZ)

  • ✓Walkthrough of CORZ's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
CORZ // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -37.20%▼ DESCENDING CHANNEL
2026-11-02O $15.00H $15.00L $13.25C $13.25VOL 8.47M
RES: $15.53SUP: $10.93SMA50: $16.07SMA200: $19.61
$31.73$26.47$21.20$15.94$10.68RES $15.53SUP $10.93$13.252026-05-042026-06-172026-08-042026-09-182026-11-02
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CORZ Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
22.3%/yr Implied 5Y Growth

vs. -37.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on CORZ today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for CORZ. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for CORZ today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CORZ)

Financials Rank #1055 of 1096 ⚔️ BLSH vs CORZ Full Matrix →

1. Head-to-Head Financials Peer Comparison (CORZ vs. BLSH, SEZL, ENVA, NNI)

Industry: Finance: Consumer Services (156 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, Core Scientific Inc. (CORZ) ranks #1055 by composite RQD confidence (26/100, grade E) and #286 by equity capitalization ($4.64B). Within this direct 5-issuer industry benchmark cohort, NNI leads on earnings valuation at 10.3x trailing P/E, while SEZL leads on capital efficiency and profitability with 38.6% ROIC and — gross margin. SEZL currently holds the highest overall quantitative score in the immediate peer group at 80/100 (B+) compared with CORZ at 26/100 (E).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
CORZ ACTIVE
Core Scientific Inc.
E 26/100 — — -35.0% -8.18% $4.64B Benchmark Subject
BLSH
Bullish
D+ 58/100 — — — -16.05% $4.54B /blsh-vs-corz →
SEZL
Sezzle Inc.
B+ 80/100 — — 38.6% +0.74% $4.52B /sezl-vs-corz →
ENVA
Enova International Inc.
C 63/100 14.4x — 17.1% -3.84% $4.43B /enva-vs-corz →
NNI
Nelnet Inc.
D+ 55/100 10.3x — 11.6% -0.87% $4.42B /nni-vs-corz →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001839341

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Core Scientific Inc. (CORZ) reported GAAP revenue of $319.0M (-37.5% vs. FY2024 revenue of $510.7M , and -36.5% cumulative change since FY2023) , GAAP net income of -$288.6M, operating cash flow of $278.3M, and free cash flow of -$450.8M (-765.7% YoY). On the balance sheet, CORZ closed FY2025 with $2.35B in total assets against $1.06B in total debt (Altman Z-Score: N/A, Piotroski F-Score: 5/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $319.0M -$288.6M $278.3M -$450.8M $2.35B $1.06B
FY2024 (FY) 2024-12-31 $510.7M -$1.44B $42.9M -$52.1M $1.48B $1.09B
FY2023 (FY) 2023-12-31 $502.4M -$246.5M $65.1M $42.5M $2.55B $596.8M

3. CORZ Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CORZ stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-02, Core Scientific Inc. (NASDAQ: CORZ) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 26/100 at a spot price of $13.25 (-8.18% 1D, market cap $4.64B). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 3/20, and SEC Balance-Sheet Forensics 5/20. Across 1096 tracked Financials issuers, CORZ ranks #1055 in composite RQD confidence.

How does CORZ compare to BLSH and SEZL in the Financials sector?

Within the Financials sector (Finance: Consumer Services), CORZ carries a Roarable E (26/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, BLSH (Bullish) holds a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $4.54B) and SEZL (Sezzle Inc.) posts a B+ grade (80/100 RQD, P/E N/A, ROIC 38.6%, cap $4.52B). Among the 5-stock peer group, NNI leads on earnings multiple (10.3x) while SEZL leads on capital efficiency (38.6% ROIC).

What are the biggest fundamental strengths and SEC risk factors for CORZ?

Per CORZ's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001839341), Core Scientific Inc. generated $319.0M in revenue (-37.5% YoY), -$288.6M in net income, and -$450.8M in free cash flow against $2.35B in total assets and $1.06B in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is CORZ trading relative to its 50-day, 200-day, and 52-week technical levels?

CORZ last traded at $13.25 (-8.18% on volume of 18,916,784 shares), positioning the stock -17.55% below its 50-day simple moving average ($16.07) and -32.43% below its 200-day simple moving average ($19.61). Across its 52-week range of $12.31 to $30.46, CORZ sits at the 5.2% percentile with a 14-day RSI of 46.9 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($11.59 to $14.91).

CORZ Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is CORZ's 12-month stock price target?

Core Scientific Inc. (CORZ) carries a 12-month consensus base price target of $11.34 (-14.4% from $13.25), with a bull-case target of $31.98 and a bear-case floor of $8.85.

Is CORZ stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates CORZ E (Strong Sell — SELL) with an RQD Confidence score of 26/100.

ROARABLE RATING BRIEF • RQD 26/100 (E) ✓ STAGE-C NUMBER FIREWALL VERIFIED

CORZ — Core Scientific Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:21:18Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, CORZ scores 26 out of 100 and carries a letter grade of E, labeled "Roarable Strong Sell — Forensic Risk / Avoid." The Fundamental Cash Engine pillar scores 4 of 20, reflecting ROIC of -35% and an FCF yield of -9.72%. The Whale 13F Flow pillar scores 6 of 20, based on institutional accumulation and options positioning. The Insider Conviction pillar scores 5 of 20, based on SEC Form 4 and Congressional PTR cluster flow. The Macro Regime Fit pillar scores 3 of 20, reflecting a Beta of 1.12 and sector sensitivity. The Forensic Balance Sheet pillar scores 8 of 20, reflecting an Altman Z of 2.5, a Piotroski F of 5/9, and Debt/Equity of 0.5.

For a prospective investor, the weakest pillars sit on the cash-generation and macro-fit side, while the balance sheet is the strongest of the five but still scores below mid-range. Upside drivers would need to come from a reversal in operating cash flow, which the source data shows as negative. Valuation tradeoffs are visible in the forward P/E of 29 set against negative trailing EPS of -0.9. The rating frames this as a forensic-risk profile rather than a cash-generative one.

Business

Core Scientific Inc. is a NASDAQ-listed issuer classified under the Financials sector and the Finance: Consumer Services industry, per the company profile. The source data does not describe its products, customers, or revenue model beyond these classifications. Per the SEC financials, the company reported FY 2025 revenue of $319.0M. The Butterfly Supply-Chain Graph lists supply chain as "NONE," so no upstream or downstream relationships are mapped.

Financial Trend

PeriodRevenueOperating IncomeNet IncomeEPSFCFCashDebt
FY 2025$319.0M$-245.6M$-288.6MN/A$-450.8M$311.4M$1060.3M
FY 2024$510.7M$-142.1M$-1437.9MN/A$-52.1M$836.2M$1088.5M
FY 2023$502.4M$9.0M$-246.5MN/A$42.5MN/A$596.8M

Per the SEC financials, revenue declined from $510.7M in FY 2024 to $319.0M in FY 2025, and operating income moved from $-142.1M to $-245.6M. Per the market data, gross margin is 0%, operating margin is -60%, and net margin is -60%, with ROIC of -35%. Per the Roarable RQD rating, the Altman Z-Score is 2.5 and the Piotroski F-Score is 5/9. Debt/Equity is 0.5 per the rating pillars, and cash fell from $836.2M to $311.4M across the reported periods.

Recent Catalysts & News Wire Analysis

Per the recent news wire, the headlines are dated within the prior 15 hours of the data timestamp. Flagged items include a Seeking Alpha report headlined "Core Scientific Wins AMD's Approval, As Meltdown/Bottoming Offers Cheap Buying Opportunity," presented as a yellow-light market wire item. A 24/7 Wall St. report flagged as a red-light risk watch item notes that Applied Digital fell 4% ahead of earnings and that IREN and Core Scientific also dropped 4%. A GuruFocus report headlined "Core Scientific (CORZ) Stock Dips Amid Elevated Options Volatili" is also present as a yellow-light wire. The remaining wire items are general market-action summaries from Yahoo Finance UK, Simply Wall St, and TradingView. The Butterfly Supply-Chain Graph reports no proprietary signals and no butterfly links.

Open Questions

  • What is the company's revenue mix and customer base, given that the source data provides only a sector and industry classification?
  • What drove the reduction in cash from $836.2M in FY 2024 to $311.4M in FY 2025 alongside FCF of $-450.8M?
  • What is the trailing P/E and EV/EBITDA, which the source data marks as unavailable?
  • What institutional and insider ownership exists, given that both holders and analyst data are empty?
  • What is the basis for the AMD approval referenced in the Seeking Alpha headline, and how does it relate to reported financials?

CORZ Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Core Scientific Inc. (CORZ) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to CORZ Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

CORZ Bull vs. Bear Conversation Board — What's Your Call at $13.25?

🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON CORZ 🐻 67% BEARISH CONVICTION
1. Pick Your Side on CORZ:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH 🎯 Target: $12.70 (-12.0%)
📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is CORZ (E • RQD 26/100) a Buy at $14.43?

Welcome to the CORZ (Core Scientific Inc.) Roar Pit. Current RQD Composite is 26/100 (Roarable Strong Sell — Forensic Risk / Avoid) in Finance: Consumer Services. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

SH ShortSeller_Dan Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $11.26 (-22.0%)
Spot @ $14.43

Pump the brakes on CORZ — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on CORZ, but look at what you are paying: current EV/EBITDA multiples with tightening sector spreads. Unless Core Scientific Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

MA MacroHawk_NYC Verified K Arena Trader 🐂 BULLISH 🎯 Target: $18.04 (+25.0%)
Spot @ $14.43

CORZ cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on CORZ, the market is fixating on short-term headline noise in Finance: Consumer Services and ignoring the balance sheet and cash flow trajectory. At $14.43 (52-wk range $12.31 - $30.46), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.36 -0.94% GLD $355.78 -1.34%